-
公开(公告)号:CA2281734A1
公开(公告)日:1998-09-03
申请号:CA2281734
申请日:1998-02-06
Applicant: ABBOTT LAB
Inventor: CHU DANIEL T , HSIAO CHI-NUNG W , LI-QUN , KERDESKY FRANCIS A J , WANG WEI-BO
IPC: C07D455/02
Abstract: A process for the preparation of a compound having formula (a) wherein R1, R2, R3, R4, and R5 are defined, from an enamine by chain expansion and ring closure followed by additional derivatization, treatment with a 3-alkoxyl-acryloyl compound, another ring closure, and converting a hydroxyl group to a leaving group.
-
公开(公告)号:CZ290252B6
公开(公告)日:2002-06-12
申请号:CZ288199
申请日:1998-02-06
Applicant: ABBOTT LAB
Inventor: WANG WEI-BO , KERDESKY FRANCIS A J , HSIAO CHI-NUNG W , LI QUN , CHU DANIEL T
IPC: C07D455/02
Abstract: In the present invention there is disclosed a process for preparing carboxylic acid of the general formula II, in which the substituents Re1 through Re5 have specific meaning, by reacting enamine with acid chloride and further by reacting the resulting intermediate with malonamic acid ester in the presence of a base. Subsequently the obtained compound is protected on the hydroxy position by treatment thereof for example with methyl chloride. The resulting compound then reacts with an alkali metal base and subsequently with 3-alkoxyacryloyl compound and the formed intermediates is reacted with a catalytic amount of acid in order to close a ring and finally the resulting acid is reacted with a halogenating agent.
-
公开(公告)号:TR199901956T2
公开(公告)日:1999-10-21
申请号:TR9901956
申请日:1998-02-06
Applicant: ABBOTT LAB
Inventor: WANG WEI-BO , KERDESKY FRANCIS A J , HSIAO CHI-NUNG W , LI QUN , CHU DANIEL T
IPC: C07D455/02
Abstract: A process for the preparation of a compound having the formula: wherein R1, R2, R3, R4, and R5 are defined, from an enamine by chain expansion and ring closure followed by additional derivatization, treatment with a 3-alkoxyl-acryloyl compound, another ring closure, and converting a hydroxyl group to a leaving group.
-
公开(公告)号:AU4751393A
公开(公告)日:1993-12-16
申请号:AU4751393
申请日:1993-09-21
Applicant: ABBOTT LAB
Inventor: SCHOENLEBER ROBERT W , KEBABIAN JOHN W , MARTIN YVONNE C , DENINNO MICHAEL P , PERNER RICHARD J , STOUT DAVID M , HSIAO CHI-NUNG W
IPC: A61K31/135 , A61K31/35 , A61K31/40 , A61K31/535 , C07C215/52 , C07C217/60 , C07C219/28 , C07C237/08 , C07C271/16 , C07C271/44 , C07C271/58 , C07C309/65 , C07C323/60 , C07D207/08 , C07D207/16 , C07D209/44 , C07D221/10 , C07D221/20 , C07D311/76 , C07D311/96 , C07D319/20 , C07D335/06 , C07D405/04 , C07D405/06 , C07D405/12 , C07D407/10 , C07D493/10 , C07K5/06
-
公开(公告)号:ES2168740T3
公开(公告)日:2002-06-16
申请号:ES98904979
申请日:1998-02-06
Applicant: ABBOTT LAB
Inventor: WANG WEI-BO , KERDESKY FRANCIS A J , HSIAO CHI-NUNG W , LI QUN , CHU DANIEL T
IPC: C07D455/02
Abstract: A process for the preparation of a compound having the formula: wherein R1, R2, R3, R4, and R5 are defined, from an enamine by chain expansion and ring closure followed by additional derivatization, treatment with a 3-alkoxyl-acryloyl compound, another ring closure, and converting a hydroxyl group to a leaving group.
-
公开(公告)号:TR9901956T2
公开(公告)日:1999-10-21
申请号:TR9901956
申请日:1998-02-06
Applicant: ABBOTT LAB
Inventor: WANG WEI-BO , KERDESKY FRANCIS A J , HSIAO CHI-NUNG W , LI QUN , CHU DANIEL T
IPC: C07D455/02
CPC classification number: C07D455/02
-
公开(公告)号:GR900100423A
公开(公告)日:1991-10-10
申请号:GR90100423
申请日:1990-05-31
Applicant: ABBOTT LAB
Inventor: SCHOENLEBER ROBERT W , MARTIN YVONNE C , PERNER RICHARD J , HSIAO CHI-NUNG W , DEBERNARDIS JOHN F , MEYER MICHAEL D , EHRLICH PAUL P , MORTON HOWARD E , KEBABIAN JOHN W , DENINNNO MICHAEL P , STOUT DAVID M , DIDOMENICO STANLEY JR , BASHA FATIMA Z DE
IPC: A61K31/13 , A61K31/135 , A61K31/16 , A61K31/335 , A61K31/40 , A61K31/403 , A61K31/404 , A61K38/00 , A61P9/00 , A61P25/00 , A61P25/18 , A61P25/30 , C07C41/02 , C07C215/48 , C07C215/64 , C07C217/56 , C07C217/74 , C07C219/28 , C07C233/18 , C07C237/08 , C07C271/16 , C07C271/44 , C07C309/65 , C07C323/60 , C07D207/08 , C07D209/08 , C07D209/62 , C07D221/06 , C07D221/10 , C07D221/20 , C07D311/76 , C07D311/78 , C07D311/96 , C07D313/08 , C07D405/04 , C07D405/06 , C07D405/12 , C07D407/04 , C07D407/12 , C07D493/10 , C07K5/06 , C07C235/08 , C07C235/18 , C07C217/58 , C07C215/50 , C07C237/22
Abstract: Novel compounds which are selective dopamine agonists are useful for treating disorders characterized by abnormal dopamine levels, such as Parkinson's Disease, as well as cardiovascular disorders.
-
公开(公告)号:NZ336876A
公开(公告)日:2000-12-22
申请号:NZ33687698
申请日:1998-02-06
Applicant: ABBOTT LAB
Inventor: WANG WEI-BO , KERDESKY FRANCIS A J , LI QUN , CHU DANIEL T , HSIAO CHI-NUNG W
IPC: C07D455/02
Abstract: Substituted pyrazole-3-yl benzazoles of formula (I) and salts thereof wherein: R1 is H, alkyl or alkyl halide; R2 is CN, alkyl, haloalkyl, alkoxy, haloalkoxy, alkylthio, haloalkylthio, alkylsulphinyl, haloalkylsulphinyl, alkylsulphonyl, or haloalkylsulphonyl; R3 is H, CN, NO2, halogen, alkyl or haloalkyl; R4 is H, halogen; R5 is H, CN, halogen, alkyl, haloalkyl, alkoxy or haloalkoxy; Z is N=C(XR6)O or N=C(XR6)S, bonded to alpha by the nitrogen, oxygen or sulphur; X is a chemical bond, oxygen, sulphur, S(O), SO2, NH or N(R7); R6 and R7 are alkyl, haloalkyl, cyanoalkyl, hydroxyalkyl, alkenyl, cyanoalkenyl, haloalkenyl, alkinyl, cyanoalkinyl, haloalkinyl, alkoxyalkyl, haloalkoxyalkyl, alkenyloxyalkyl, alkinyloxyalkyl, cycloalkyloxyalkyl, aminoalkyl, alkylaminoalkyl, di(alkyl)aminoalkyl, alkylthioalkyl, haloalkylthioalkyl, alkenylthio alkyl, alkinylthioalkyl, alkylsulphinylalkyl, haloalkylsulphinylalkyl, alkenylsulphinylalkyl, alkinylsulphinylalkyl, alkylsulphonylalkyl, haloalkylsulphonylalkyl, alkenylsulphonylalkyl, alkinylsulphonylalkyl, hydroxycarbonylalkyl, alkoxycarbonylalkyl, which can carry a CN or alkoxycarbonyl group, alkylthiocarbonylalkyl, aminocarbonylalkyl, alkylaminocarbonylalkyl, di(alkyl)aminocarbonylalkyl, dialkylphosphonylalkyl, alkoxyiminoalkyl, alkenyloxyiminoalkyl, optionally substituted cycloalkyl, cycloalkylalkyl, phenyl, phenylalkyl, 3 to 7member heterocyclic or heterocyclylalkyl, wherein each cycloalkyl ring and each heterocyclyl ring contain a CO or CS ring member; if X is a chemical bond, O, S, NH or N(R7), R6 also being alkylcarbonyl, haloalkylcarbonyl, alkoxycarbonyl, alkylsulphonyl or haloalkylsulphonyl; if X is a chemical bond, R6 additionally designating CN, SH, NH2, halogen, CH2CH(halogen)R8, CH=CHR8 or CH=C(halogen)R8, or R6 plus R7 designating an optionally substituted 1,3propylene, tetramethylene, pentamethylene or ethylene oxyethylene chain R8 is COOH, alkoxycarbonyl, alkylthiocarbonyl, CONH2, alkylaminocarbonyl, dialkylaminocarbonyl or dialkylphosphonyl. These substances are useful as herbicides and for the desiccation and/or defoliation of plants
-
公开(公告)号:NO994108A
公开(公告)日:1999-10-25
申请号:NO994108
申请日:1999-08-25
Applicant: ABBOTT LAB
Inventor: WANG WEI-BO , KERDESKY FRANCIS A J , HSIAO CHI-NUNG W , LI QUN , CHU DANIEL T
IPC: C07D455/02
CPC classification number: C07D455/02
-
公开(公告)号:DK0474767T3
公开(公告)日:1996-07-15
申请号:DK90909264
申请日:1990-05-22
Applicant: ABBOTT LAB
Inventor: DEBERNARDIS JOHN F , DE BISWANATH , SCHOENLEBER ROBERT W , KEBABIAN JOHN W , MARTIN YVONNE C , DENINNO MICHAEL P , PERNER RICHARD J , STOUT DAVID M , HSIAO CHI-NUNG W , DIDOMENICO STANLEY JR , BASHA FATIMA Z , MEYER MICHEAL D , EHRLICH PAUL P , CAMPBELL JAMES R , MORTON HOWARD E , LIJEWSKI LINDA M
IPC: A61K31/13 , A61K31/135 , A61K31/16 , A61K31/335 , A61K31/40 , A61K31/403 , A61K31/404 , A61K38/00 , A61P9/00 , A61P25/00 , A61P25/18 , A61P25/30 , C07C41/02 , C07C215/48 , C07C215/64 , C07C217/56 , C07C217/74 , C07C219/28 , C07C233/18 , C07C237/08 , C07C271/16 , C07C271/44 , C07C309/65 , C07C323/60 , C07D207/08 , C07D209/08 , C07D209/62 , C07D221/06 , C07D221/10 , C07D221/20 , C07D311/76 , C07D311/78 , C07D311/96 , C07D313/08 , C07D405/04 , C07D405/06 , C07D405/12 , C07D407/04 , C07D407/12 , C07D493/10 , C07K5/06 , C07D409/04 , A01N43/00 , A01N33/00 , A61K31/395 , A61K31/235 , C07D209/56 , C07D211/00 , C07D311/74 , C07C69/76 , C07D487/00
Abstract: Novel compounds which are selective dopamine agonists are useful for treating disorders characterized by abnormal dopamine levels, such as Parkinson's Disease, as well as cardiovascular disorders.
-
-
-
-
-
-
-
-
-